FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2111042503> ?p ?o ?g. }

• W2111042503 endingPage "642" @default.
• W2111042503 startingPage "632" @default.
• W2111042503 abstract "Abstract Background: Reestablishment of metastasis suppressor gene expression may constitute a therapeutic strategy for high-risk breast cancer patients. We previously showed that medroxyprogesterone acetate (MPA), a progestin that has been tested as treatment for advanced breast cancer, elevates expression of the Nm23-H1 metastasis suppressor gene in hormone receptor–negative metastatic human breast carcinoma cell lines in vitro via a glucocorticoid receptor–based mechanism. Here, we tested whether MPA treatment inhibits metastatic colonization of a hormone receptor–negative breast cancer cell line in vivo. Methods: We tested the soft-agar colony-forming efficiency of untransfected MDA-MB-231T human breast carcinoma cells and MDA-MB-231T cells transfected with antisense Nm23-H1 in the presence and absence of MPA. Pharmacokinetic studies were used to establish dose and injection schedules that led to MPA serum levels in mice similar to those achievable in humans. For in vivo studies, nude mice were injected intravenously with MDA-MB-231T cells. After 4 weeks, mice were randomized to control or MPA arms. Endpoints included incidence, number, and size of gross pulmonary metastases; Nm23-H1 protein expression in gross metastases; and side effects. All statistical tests were two-sided. Results: MPA reduced colony formation of MDA-MB-231T cells by 40%–50% but had no effect on colony formation of Nm23-H1 antisense transfectants. Metastases developed in 100% (95% confidence interval [CI] = 78% to 100% and 77% to 100%, respectively) of control mice injected with MDA-MB-231T cells. In two independent experiments, only 73% (95% CI = 45% to 92%) and 64% (95% CI = 35% to 87%) of mice injected with 2 mg of MPA developed metastases. Mice injected with 2 mg of MPA showed reductions in the mean numbers, per mouse, of all metastases and of large (>3 mm) metastases ( P = .04 and .013, respectively). Nm23-H1 was expressed at high levels in 43% of pulmonary metastases in MPA-treated mice but only 13% of metastases in untreated mice. Mice receiving at least 1-mg doses of MPA gained more weight than control-treated mice but exhibited no bone density alterations or abnormal mammary fat pad histology. Conclusion: Our preclinical results show that MPA appears to elevate Nm23-H1 metastasis suppressor gene expression, thereby reducing metastatic colonization. The data suggest a new use for an old agent in a molecularly defined subset of breast cancer patients." @default.
• W2111042503 created "2016-06-24" @default.
• W2111042503 creator A5001321994 @default.
• W2111042503 creator A5003084219 @default.
• W2111042503 creator A5009003104 @default.
• W2111042503 creator A5022589897 @default.
• W2111042503 creator A5024598099 @default.
• W2111042503 creator A5025810550 @default.
• W2111042503 creator A5034583993 @default.
• W2111042503 creator A5035391817 @default.
• W2111042503 creator A5036400845 @default.
• W2111042503 creator A5044239219 @default.
• W2111042503 creator A5071802503 @default.
• W2111042503 creator A5078606535 @default.
• W2111042503 creator A5080778766 @default.
• W2111042503 date "2005-05-04" @default.
• W2111042503 modified "2023-10-11" @default.
• W2111042503 title "Medroxyprogesterone Acetate Elevation of Nm23-H1 Metastasis Suppressor Expression in Hormone Receptor–Negative Breast Cancer" @default.
• W2111042503 cites W1527136114 @default.
• W2111042503 cites W194764232 @default.
• W2111042503 cites W1965059912 @default.
• W2111042503 cites W1967612488 @default.
• W2111042503 cites W1971344086 @default.
• W2111042503 cites W1971901406 @default.
• W2111042503 cites W1972435524 @default.
• W2111042503 cites W1975984713 @default.
• W2111042503 cites W1976226412 @default.
• W2111042503 cites W1980562610 @default.
• W2111042503 cites W1981513125 @default.
• W2111042503 cites W1989196707 @default.
• W2111042503 cites W1991018402 @default.
• W2111042503 cites W2003367190 @default.
• W2111042503 cites W2007599495 @default.
• W2111042503 cites W2007906891 @default.
• W2111042503 cites W2018875909 @default.
• W2111042503 cites W2021434111 @default.
• W2111042503 cites W2023395420 @default.
• W2111042503 cites W2024625513 @default.
• W2111042503 cites W2037729875 @default.
• W2111042503 cites W2043078136 @default.
• W2111042503 cites W2045959948 @default.
• W2111042503 cites W2051473363 @default.
• W2111042503 cites W2056559696 @default.
• W2111042503 cites W2056760436 @default.
• W2111042503 cites W2057292695 @default.
• W2111042503 cites W2058205300 @default.
• W2111042503 cites W2059489770 @default.
• W2111042503 cites W2060436232 @default.
• W2111042503 cites W2074517459 @default.
• W2111042503 cites W2075169407 @default.
• W2111042503 cites W2076234060 @default.
• W2111042503 cites W2079292274 @default.
• W2111042503 cites W2082999114 @default.
• W2111042503 cites W2084416246 @default.
• W2111042503 cites W2086194247 @default.
• W2111042503 cites W2090282678 @default.
• W2111042503 cites W2094964650 @default.
• W2111042503 cites W2102744337 @default.
• W2111042503 cites W2104801251 @default.
• W2111042503 cites W2121456510 @default.
• W2111042503 cites W2148208680 @default.
• W2111042503 cites W2149685341 @default.
• W2111042503 cites W2155617007 @default.
• W2111042503 cites W2164225875 @default.
• W2111042503 cites W2181050057 @default.
• W2111042503 cites W2284884908 @default.
• W2111042503 cites W2335673395 @default.
• W2111042503 cites W4231268111 @default.
• W2111042503 cites W4245430470 @default.
• W2111042503 cites W4248526249 @default.
• W2111042503 cites W4253947191 @default.
• W2111042503 cites W4255880228 @default.
• W2111042503 cites W4256185042 @default.
• W2111042503 cites W2006957191 @default.
• W2111042503 doi "https://doi.org/10.1093/jnci/dji111" @default.
• W2111042503 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/15870434" @default.
• W2111042503 hasPublicationYear "2005" @default.
• W2111042503 type Work @default.
• W2111042503 sameAs 2111042503 @default.
• W2111042503 citedByCount "116" @default.
• W2111042503 countsByYear W21110425032012 @default.
• W2111042503 countsByYear W21110425032013 @default.
• W2111042503 countsByYear W21110425032014 @default.
• W2111042503 countsByYear W21110425032015 @default.
• W2111042503 countsByYear W21110425032016 @default.
• W2111042503 countsByYear W21110425032017 @default.
• W2111042503 countsByYear W21110425032018 @default.
• W2111042503 countsByYear W21110425032019 @default.
• W2111042503 countsByYear W21110425032020 @default.
• W2111042503 countsByYear W21110425032021 @default.
• W2111042503 countsByYear W21110425032023 @default.
• W2111042503 crossrefType "journal-article" @default.
• W2111042503 hasAuthorship W2111042503A5001321994 @default.
• W2111042503 hasAuthorship W2111042503A5003084219 @default.
• W2111042503 hasAuthorship W2111042503A5009003104 @default.
• W2111042503 hasAuthorship W2111042503A5022589897 @default.
• W2111042503 hasAuthorship W2111042503A5024598099 @default.
• W2111042503 hasAuthorship W2111042503A5025810550 @default.

• next